Infectious Disease Research Institute Partners with RTP CRO FHI Clinical for COVID-19 Clinical Trial

Infectious Disease Research Institute Partners with RTP CRO FHI Clinical for COVID-19 Clinical Trial

The Infectious Disease Research Institute (IDRI), a Seattle-based not-for-profit organization, has partnered with a full-service, Research Triangle, NC-based contract research organization called FHI Clinical to support full-service research capabilities for an immunotherapy clinical trial to combat moderate to severe cases of COVID-19.

TrialSite News recently introduced Celularity, a clinical-stage therapeutic company to launch a clinical trial to investigate the use of Celularity’s NK cell therapy, currently under study for the treatment of various hematologic cancers and solid tumors, as a potential treatment option against COVID-19.

Can Cell Therapy Help Address Crisis?

The hope is that the Celularity’s cell therapy (IMPACT™ Platform) can be a way of offering patients the immune cells that might make a difference in combating the deadly pathogen. Novel therapies may make a difference, reports Ted Fitzgerald, FHI Clinical president and CEO. Fitzgerald noted, “When an outbreak like coronavirus occurs, new therapies and vaccines are vital and require rapid start-up of clinical trials.”

FHI Clinical Outbreak Guide

FHI offers information on the importance of building...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee